Holgate ST. Pathogenesis of asthma. Clin Exp Allergy. 2008;38(6):872–97. https://doi.org/10.1111/j.1365-2222.2008.02971.x.
CAS Article PubMed Google Scholar
Ishmael FT. The inflammatory response in the pathogenesis of asthma. J Am Osteopath Assoc. 2011;111(11 Suppl 7):S11–7.
•• Global Initiative for Asthma. Global strategy for asthma management and prevention. 2020. https://ginasthma.org/. Accessed 5 May 2021. The updated Global Strategy for Asthma Management and Prevention Guide was released by Global Initiative for Asthma (GINA) in 2019, based on the growing evidence on the non-safety of SABA-only therapy and superiority of the as-needed ICS-formoterol combinations over maintenance ICS regimens.
Mulgirigama A, Barnes N, Fletcher M, Pedersen S, Pizzichini E, Tsiligianni I. A review of the burden and management of mild asthma in adults - implications for clinical practice. Respir Med. 2019;152:97–104. https://doi.org/10.1016/j.rmed.2019.04.024.
Choby GW, Lee S. Pharmacotherapy for the treatment of asthma: current treatment options and future directions. Int Forum Allergy Rhinol. 2015;5(Suppl1):S35-40. https://doi.org/10.1002/alr.21592.
Global Initiative for Asthma (GINA). What’s new in GINA 2021?. 2021. https://ginasthma.org/. Accessed 5 May 2021.
•• Muneswarao J, Hassali MA, Ibrahim B, Saini B, Ali IAH, Verma AK. It is time to change the way we manage mild asthma: an update in GINA 2019. Respir Res. 2019;20(1):183. https://doi.org/10.1186/s12931-019-1159-y. The new GINA 2019 recommendations for asthma treatment no longer support the symptom-driven SABA-only therapy in mild asthma, instead offer new off-label approaches for the two treatment steps (Steps 1 and 2), including symptom-driven (as-needed) low dose ICS-formoterol and “low dose ICS taken whenever SABA is taken”.
Lugogo N, Gilbert I, Tkacz J, Gandhi H, Goshi N, Lanz MJ. Real-world patterns and implications of short-acting β2-agonist use in patients with asthma in the United States. Ann Allergy Asthma Immunol. 2021;126(6):681-9.e1. https://doi.org/10.1016/j.anai.2021.01.024.
CAS Article PubMed Google Scholar
Laforest L, Licaj I, Devouassoux G, Chatte G, Martin J, Van Ganse E. Asthma drug ratios and exacerbations: claims data from universal health coverage systems. Eur Respir J. 2014;43(5):1378–86. https://doi.org/10.1183/09031936.00100113.
Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992;326(8):501–6. https://doi.org/10.1056/NEJM199202203260801.
CAS Article PubMed Google Scholar
O’Byrne PM, Reddel HK, Beasley R. The management of mild asthma. Eur Respir J. 2021;57(4):2003051. https://doi.org/10.1183/13993003.03051-2020.
CAS Article PubMed Google Scholar
Rajan S, Gogtay NJ, Konwar M, Thatte UM. The global initiative for asthma guidelines (2019): change in the recommendation for the management of mild asthma based on the SYGMA-2 trial - A critical appraisal. Lung India. 2020;37(2):169–73. https://doi.org/10.4103/lungindia.lungindia_308_19.
Article PubMed PubMed Central Google Scholar
Global Asthma Network. The global asthma report. 2014. http://globalasthmareport.org/2014/Global_Asthma_Report_2014.pdf. Accessed 20 Feb 2021.
Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. Asthma Res Pract. 2017;3:1. https://doi.org/10.1186/s40733-016-0029-3.
Article PubMed PubMed Central Google Scholar
Dharmage SC, Perret JL, Custovic A. Epidemiology of asthma in children and adults. Front Pediatr. 2019;7:246. https://doi.org/10.3389/fped.2019.00246.
Article PubMed PubMed Central Google Scholar
Enilari O, Sinha S. The global impact of asthma in adult populations. Ann Glob Health. 2019;85(1):2. https://doi.org/10.5334/aogh.2412.
To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012;12:204. https://doi.org/10.1186/1471-2458-12-204.
Article PubMed PubMed Central Google Scholar
Kurt E, Metintas S, Basyigit I, Bulut I, Coskun E, Dabak S, et al. Prevalence and risk factors of allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults. Eur Respir J. 2009;33(4):724–33. https://doi.org/10.1183/09031936.00082207.
CAS Article PubMed Google Scholar
Sekerel BE, Gemicioglu B, Soriano JB. Asthma insights and reality in Turkey (AIRET) study. Respir Med. 2006;100(10):1850–4. https://doi.org/10.1016/j.rmed.2006.01.024.
Altman MC, Lai Y, Nolin JD, Long S, Chen CC, Piliponsky AM, et al. Airway epithelium-shifted mast cell infiltration regulates asthmatic inflammation via IL-33 signaling. J Clin Invest. 2019;129(11):4979–91. https://doi.org/10.1172/JCI126402.
CAS Article PubMed PubMed Central Google Scholar
Durrani SR, Viswanathan RK, Busse WW. What effect does asthma treatment have on airway remodeling? Current perspectives J Allergy Clin Immunol. 2011;128:439–48. https://doi.org/10.1016/j.jaci.2011.06.002.
Vignola AM, Chanez P, Campbell AM, Souques F, Lebel B, Enander I, et al. Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med. 1998;157:403–9. https://doi.org/10.1164/ajrccm.157.2.96-08040.
CAS Article PubMed Google Scholar
Mims JW. Asthma: definitions and pathophysiology. Int Forum Allergy Rhinol. 2015;5(Suppl 1):S2-6. https://doi.org/10.1002/alr.21609.
Banno A, Reddy AT, Lakshmi SP, Reddy RC. Bidirectional interaction of airway epithelial remodeling and inflammation in asthma. Clin Sci (Lond). 2020;134(9):1063–79. https://doi.org/10.1042/CS20191309.
Russell RJ, Brightling C. Pathogenesis of asthma: implications for precision medicine. Clin Sci (Lond). 2017;131(14):1723–35. https://doi.org/10.1042/CS20160253.
Rytilä P, Metso T, Heikkinen K, Saarelainen P, Helenius IJ, Haahtela T. Airway inflammation in patients with symptoms suggesting asthma but with normal lung function. Eur Respir J. 2000;16(5):824–30. https://doi.org/10.1183/09031936.00.16582400.
Tillie-Leblond I, Montani D, Crestani B, de Blic J, Humbert M, Tunon-de-Lara M, et al. Relation between inflammation and symptoms in asthma. Allergy. 2009;64(3):354–67. https://doi.org/10.1111/j.1398-9995.2009.01971.x.
CAS Article PubMed Google Scholar
Mogensen I, Alving K, Jacinto T, Fonseca J, Janson C, Malinovschi A. Simultaneously elevated FeNO and blood eosinophils relate to asthma morbidity in asthmatics from NHANES 2007–12. Clin Exp Allergy. 2018;48(8):935–43. https://doi.org/10.1111/cea.13137.
CAS Article PubMed Google Scholar
Mogensen I, Alving K, Bjerg A, Borres MP, Hedlin G, Sommar J, et al. Simultaneously elevated exhaled nitric oxide and serum-eosinophil cationic protein relate to recent asthma events in asthmatics in a cross-sectional population-based study. Clin Exp Allergy. 2016;46(12):1540–8. https://doi.org/10.1111/cea.12792.
CAS Article PubMed Google Scholar
van der Valk RJ, Baraldi E, Stern G, Frey U, de Jongste JC. Daily exhaled nitric oxide measurements and asthma exacerbations in children. Allergy. 2012;67(2):265–71. https://doi.org/10.1111/j.1398-9995.2011.02734.x.
CAS Article PubMed Google Scholar
Jeffery PK, Haahtela T. Allergic rhinitis and asthma: inflammation in a one-airway condition. BMC Pulm Med. 2006;6 Suppl 1(Suppl 1):S5. https://doi.org/10.1186/1471-2466-6-S1-S5
Dusser D, Montani D, Chanez P, de Blic J, Delacourt C, Deschildre A, et al. Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations. Allergy. 2007;62(6):591–604. https://doi.org/10.1111/j.1398-9995.2007.01394.x.
CAS Article PubMed Google Scholar
Levy ML, Andrews R, Buckingham R, Evans H, Francis C, Houston R, et al. Why asthma still kills: the national review of asthma deaths (NRAD) confidential enquiry report. London, UK: Royal College of Physicians. 2014. http://www.rcplondon.ac.uk/sites/default/files/why-asthma-still-kills-full-report.pdf. Accessed 20 Feb 2021.
Ding B, DiBonaventura M, Karlsson N, Ling X. A cross-sectional assessment of the prevalence and burden of mild asthma in urban China using the 2010, 2012, and 2013 China National Health and Wellness Surveys. J Asthma. 2017;54(6):632–43. https://doi.org/10.1080/02770903.2016.1255750.
Bloom CI, Nissen F, Douglas IJ, Smeeth L, Cullinan P, Quint JK. Exacerbation risk and characterisation of the UK’s asthma population from infants to old age. Thorax. 2018;73(4):313–20. https://doi.org/10.1136/thoraxjnl-2017-210650.
FitzGerald JM, Barnes PJ, Chipps BE, Jenkins CR, O’Byrne PM, Pavord ID, et al. The burden of exacerbations in mild asthma: a systematic review. ERJ Open Res. 2020;6(3):00359–2019. https://doi.org/10.1183/23120541.00359-2019.
Article PubMed PubMed Central Google Scholar
Chuchalin A, Jacques L, Frith L. Salmeterol/fluticasone propionate via Diskus™ once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids. Clin Drug Investig. 2008;28(3):169–81. https://doi.org/10.2165/00044011-200828030-00004.
CAS Article PubMed Google Scholar
Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet. 2003;361(9363):1071–6. https://doi.org/10.1016/S0140-6736(03)12891-7.
CAS Article PubMed Google Scholar
Fuhlbrigge AL, Adams RJ, Guilbert TW, Grant E, Lozano P, Janson SL, et al. The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am J Respir Crit Care Med. 2002;166(8):1044–9. https://doi.org/10.1164/rccm.2107057.
Crompton G. A brief history of inhaled asthma therapy over the last fifty years. Prim Care Respir J. 2006;15(6):326–31. https://doi.org/10.1016/j.pcrj.2006.09.002.
Article PubMed PubMed Central Google Scholar
Foster JM, Beasley R, Braithwaite I, Harrison T, Holliday M, Pavord I, et al. Patient experiences of as-needed budesonide-formoterol by Turbuhaler® for treatment of mild asthma; a qualitative study. Respir Med. 2020;175: 106154. https://doi.org/10.1016/j.rmed.2020.106154.
CAS Article PubMed Google Scholar
Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343(5):332–6. https://doi.org/10.1056/NEJM200008033430504.
留言 (0)